Analyst Ratings for Medivation Inc (MDVN)

Updated: 2016-09-27

A number of analysts gave price targets for MDVN. The most optimistic price target was 82, implying a possible profit of 0.69 percent. The minimum price target given was 64, implying potential capital losses of -21.41 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

In the last 30 days, analysts have changed their quarterly earnings estimates downwards by an average of -1.32 percent. That number becomes 1.37 percent if we expand the time horizon to include the past 3 months instead of just one. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. If we look at the last 90 days instead, we find a net average change of 8.29 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 1 analysts made negative revisions. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 1 analysts that revised their FY estimates downwards.

In the last 52-weeks, MDVN has achieved a high of 81.48 and a low of 26.41. Currently the stock is 208.37 percent higher than its low, and 0.05 percent below the high. MDVN has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The MDVN value stock report compares MDVN to some of its peers using value stock charts. The market cap of MDVN is $13.57 billion. MDVN is estimated to release their earnings results for the quarter on 2016-11-03, days from today.